Physician profile
Chad D Goffstein
NPI 1740501006
$466.79
in general payments reported to CMS, 2019-2025
7 companies · $170 in 2025
The $170 reported for 2025 was more than what 77% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.29 · 2023: $16.43 · 2024: $262 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.41 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $127.24 | 2025 | Fisher & Paykel Healthcare |
| Cerus Corporation | $97.52 | 2024 | Intercept Blood System For Platelets |
| Becton, Dickinson and Company | $92.86 | 2024 | Hemosphere |
| Boston Scientific Corporation | $67.52 | 2023-2025 | General - Pain Management |
| Acera Surgical, INC. | $45.27 | 2024-2025 | Restrata Wound Matrix |
| Vyaire Medical, INC. | $18.29 | 2022 | |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Goffstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.